{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T04:42:48Z","timestamp":1779079368090,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.hpb.2024.10.006","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T05:25:52Z","timestamp":1729229152000},"page":"94-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identifying an optimal cancer risk threshold for resection of pancreatic intraductal papillary mucinous neoplasms"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-6477","authenticated-orcid":false,"given":"Greg D.","family":"Sacks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Wojtalik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah R.","family":"Kaslow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8341-0379","authenticated-orcid":false,"given":"Christina A.","family":"Penfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-3787","authenticated-orcid":false,"given":"Stella K.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.B.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5463-5250","authenticated-orcid":false,"given":"Ammar A.","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.S.","family":"Braithwaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2024.10.006_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00535-005-1646-4","article-title":"Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas","volume":"40","author":"Tanaka","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.hpb.2024.10.006_bib2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.hpb.2024.10.006_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/SLA.0000000000002015","article-title":"Development and validation of a multi-institutional preoperative nomogram for predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas","volume":"267","author":"Attiyeh","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib4","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1245\/s10434-013-3207-z","article-title":"Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram","volume":"20","author":"Correa-Gallego","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.10.006_bib5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/SLA.0000000000001784","article-title":"Surgeon Perception of Risk and Benefit in the Decision to Operate","volume":"264","author":"Sacks","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6947-14-47","article-title":"How do physicians decide to treat: an empirical evaluation of the threshold model","volume":"14","author":"Djulbegovic","year":"2014","journal-title":"BMC Med Inform Decis"},{"key":"10.1016\/j.hpb.2024.10.006_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/0272989X14525855","article-title":"Evaluation of physicians\u2019 cognitive styles","author":"Djulbegovic","year":"2014","journal-title":"Med Decis Making"},{"key":"10.1016\/j.hpb.2024.10.006_bib8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0272989X0202200411","article-title":"Primary prevention drug therapy: can it meet patients\u2019 requirements for reduced risk?","volume":"22","author":"Llewellyn-Thomas","year":"2002","journal-title":"Med Decis Making"},{"key":"10.1016\/j.hpb.2024.10.006_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.gastro.2015.01.015","article-title":"American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts","volume":"148","author":"Vege","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2024.10.006_bib10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/gutjnl-2018-316027","article-title":"European evidence-based guidelines on pancreatic cystic neoplasms","volume":"67","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2024.10.006_bib11","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.14309\/ajg.0000000000000378","article-title":"\u201cTrivial\u201d cysts redefine the risk of cancer in presumed branch-duct intraductal papillary mucinous neoplasms of the pancreas: a potential target for follow-up discontinuation?","volume":"114","author":"Marchegiani","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hpb.2024.10.006_bib13","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s10620-009-1014-y","article-title":"Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis","volume":"55","author":"Huang","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.hpb.2024.10.006_bib14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMsa012337","article-title":"Hospital volume and surgical mortality in the United States","volume":"346","author":"Birkmeyer","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hpb.2024.10.006_bib15","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hpb.2024.10.006_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijsu.2019.09.014","article-title":"Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma: a systematic review and meta-analysis","volume":"71","author":"Aronsson","year":"2019","journal-title":"Int J Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib17","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2024.10.006_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamaoncol.2020.7328","article-title":"Efficacy of perioperative chemotherapy for resectable pancreatic adenocarcinoma","volume":"7","author":"Sohal","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hpb.2024.10.006_bib19","first-page":"1","article-title":"United States Life Tables, 2019","volume":"70","author":"Arias","year":"2022","journal-title":"National Vital Statistics Reports Centers Dis Control Prev National Cent Heal Statistics National Vital Statistics Syst"},{"key":"10.1016\/j.hpb.2024.10.006_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"key":"10.1016\/j.hpb.2024.10.006_bib21","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/bjs.11293","article-title":"Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 Mm or less","volume":"106","author":"Jung","year":"2019","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJM198005153022003","article-title":"The threshold approach to clinical decision making","volume":"302","author":"Pauker","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hpb.2024.10.006_bib23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/jgs.15272","article-title":"Influences on care preferences of older people with advanced illness: a systematic review and thematic synthesis","volume":"66","author":"Etkind","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.hpb.2024.10.006_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/0272989X9801800302","article-title":"Using a treatment-tradeoff method to elicit preferences for the treatment of locally advanced non-small-cell lung cancer","volume":"18","author":"Brundage","year":"1998","journal-title":"Med Decis Making"},{"key":"10.1016\/j.hpb.2024.10.006_bib25","first-page":"1218","article-title":"Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study","volume":"323","author":"Devereaux","year":"2001","journal-title":"BMJ Clin Res Ed"},{"key":"10.1016\/j.hpb.2024.10.006_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jss.2014.02.015","article-title":"Patients\u2019 preferences and trade-offs for the treatment of early stage hepatocellular carcinoma","volume":"189","author":"Molinari","year":"2014","journal-title":"J Surg Res"},{"key":"10.1016\/j.hpb.2024.10.006_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40258-019-00521-3","article-title":"Using the threshold technique to elicit patient preferences: an introduction to the method and an overview of existing empirical applications","volume":"18","author":"Hauber","year":"2020","journal-title":"Appl Health Econ Health Pol"},{"key":"10.1016\/j.hpb.2024.10.006_bib28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.hpb.2024.10.006_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamasurg.2017.4587","article-title":"Comparative effectiveness of resection vs surveillance for pancreatic branch duct intraductal papillary mucinous neoplasms with worrisome features","volume":"153","author":"Hu","year":"2017","journal-title":"Jama Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.gastro.2009.10.001","article-title":"Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using markov-based clinical nomograms","volume":"138","author":"Weinberg","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2024.10.006_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/SLA.0000000000002380","article-title":"Health-related quality of life and functional outcomes in 5-year survivors after pancreaticoduodenectomy","volume":"266","author":"Fong","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10689-020-00171-8","article-title":"Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance","volume":"19","author":"Overbeek","year":"2020","journal-title":"Fam Cancer"},{"key":"10.1016\/j.hpb.2024.10.006_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000430","article-title":"Factors affecting the rates of adherence to surveillance recommendations for incidental pancreatic cystic lesions in a large urban safety net hospital","volume":"7","author":"Canakis","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.hpb.2024.10.006_bib34","doi-asserted-by":"crossref","first-page":"d1672","DOI":"10.1136\/bmj.d1672","article-title":"Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis","volume":"342","author":"Greving","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.hpb.2024.10.006_bib35","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2147\/RMHP.S262171","article-title":"Cost-Effectiveness analysis of colorectal cancer screening: a systematic review","volume":"13","author":"Khalili","year":"2020","journal-title":"Risk Manag Healthc Pol"},{"key":"10.1016\/j.hpb.2024.10.006_bib36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/SLA.0000000000000378","article-title":"Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer","volume":"260","author":"Merkow","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00595-016-1426-1","article-title":"Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review","volume":"47","author":"Watanabe","year":"2017","journal-title":"Surg Today"},{"key":"10.1016\/j.hpb.2024.10.006_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/00365521.2016.1228118","article-title":"Factors influencing receipt of adjuvant chemotherapy after surgery for pancreatic cancer: a two-center retrospective cohort study","volume":"52","author":"\u00c5kerberg","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.hpb.2024.10.006_bib39","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.surg.2015.12.024","article-title":"Long-term survival in patients with pancreatic ductal adenocarcinoma","volume":"159","author":"Stark","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2024.10.006_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1457496916645963","article-title":"The results of pancreatic resections and long-term survival for pancreatic ductal adenocarcinoma: a single-institution experience","volume":"106","author":"Sepp\u00e4nen","year":"2016","journal-title":"Scand J Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jamasurg.2015.0668","article-title":"Characteristics of 10-year survivors of pancreatic ductal adenocarcinoma","volume":"150","author":"Paniccia","year":"2015","journal-title":"Jama Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib42","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1245\/s10434-012-2702-y","article-title":"Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation","volume":"20","author":"LaFemina","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.10.006_bib43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cgh.2006.01.018","article-title":"Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy","volume":"4","author":"L\u00e9vy","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2024.10.006_bib44","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/SLA.0b013e3182a18f48","article-title":"Branch duct intraductal papillary mucinous neoplasms","volume":"258","author":"Sahora","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib45","doi-asserted-by":"crossref","first-page":"82953","DOI":"10.18632\/oncotarget.12761","article-title":"An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma","volume":"7","author":"P\u00e9ron","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.hpb.2024.10.006_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cgh.2010.09.008","article-title":"Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms","volume":"9","author":"Kang","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2024.10.006_bib47","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11605-011-1757-6","article-title":"Outcomes of primary surveillance for intraductal papillary mucinous neoplasm","volume":"16","author":"Cauley","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib48","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.dld.2012.06.005","article-title":"Carcino embryonic antigen and long-term follow-up of mucinous pancreatic cysts including intraductal papillary mucinous neoplasm","volume":"44","author":"Othman","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.hpb.2024.10.006_bib49","doi-asserted-by":"crossref","DOI":"10.1177\/14574969221076792","article-title":"A retrospective study of intraductal papillary neoplasia of the pancreas (IPMN) under surveillance","volume":"111","author":"Johansson","year":"2022","journal-title":"Scand J Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jamcollsurg.2011.04.003","article-title":"Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American joint committee on cancer stage","volume":"213","author":"Waters","year":"2011","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hpb.2024.10.006_bib51","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/cncr.26365","article-title":"Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer","volume":"118","author":"Murphy","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2024.10.006_bib52","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.2147\/CMAR.S172704","article-title":"Cost-Effectiveness analysis of adjuvant treatment for resected pancreatic cancer in China based on the ESPAC-4 trial","volume":"10","author":"Huang","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.hpb.2024.10.006_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.surg.2020.04.052","article-title":"Cost-Effectiveness of consensus guideline based management of pancreatic cysts: the sensitivity and specificity required for guidelines to Be cost-effective","volume":"168","author":"Sharib","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2024.10.006_bib54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpainsymman.2011.09.001","article-title":"Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303)","volume":"43","author":"Romanus","year":"2012","journal-title":"J Pain Symptom Manag"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X24023761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X24023761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T03:38:02Z","timestamp":1767238682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X24023761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1365182X24023761"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2024.10.006","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying an optimal cancer risk threshold for resection of pancreatic intraductal papillary mucinous neoplasms","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2024.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}